Rise in global geriatric population and increasing prevalence of chronic diseases are among the key factors driving market revenue growth during the forecast period
According to Emergen Research, the global human microbiome modulators market size was USD 1.65 billion in 2020 and is expected to reach USD 5.24 billion in 2027 and register a revenue CAGR of 16.5% during the forecast period, 2020-2027.
Rise in geriatric population across the globe, rising prevalence of chronic and acute diseases, and increasing cases of lifestyle-induced disorders including diabetes, high blood pressure, etc. are key factors expected to drive market revenue growth over the forecast period. Human microbiome modulation is a novel strategy developed with the aim to reverse the established technique of microbial dysbiosis. The technique aids in the prevention and treatment of colorectal cancer (CRC). Increasing knowledge about the way gut microbiome contributes to carcinogenesis and interferes with the treatment has further increased focus on restoring gut microbial homeostasis as a potential strategy for prevention and treatment of colorectal cancer. Human microbiome has been a key topic of interest for research and clinical applications over the last couple of years and increasing efforts to bridge the gap between research and clinical applications has accelerated the progress of targeted, personalized therapy. This is another key factor expected to fuel revenue growth over the forecast period.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/376
Growing need for preventive medicine, increasing applications of human microbiome modulation technique in treatment of infectious, neurological, oncological, gastrointestinal, and dermatological disorders are other key factors contributing to the global human microbiome modulators market revenue growth. Furthermore, increasing adoption of different human microbiome modulation strategies including prebiotics, probiotics, antibiotics, post-biotics, and fecal microbiota transplantation (FMT) is expected to bolster market revenue growth over the upcoming years. However, stringent regulations regarding use of postbiotics and prebiotics and lack of research activities are some key factors expected to hamper market growth to a significant extent going ahead.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Probiotics and Creams Segment Accounted for Largest Revenue Share in 2020:
Based on product type, the probiotics and creams segment accounted for the largest revenue share in the global human microbiome modulators market in 2020. Growing use of probiotics owing to their effectiveness in adjusting the structure and function of the human microbiome is a key factor contributing to the growth of this segment. Growing geriatric population, increasing prevalence of gastrointestinal and metabolic disorders such as diarrhea, irritable bowel syndrome, colitis, enterocolitis, and acute gastroenteritis are other factors driving this segment’s growth.
North America Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America human microbiome modulators market held the largest revenue share in the global market in 2020 due to many favorable factors. Growing geriatric population, increasing prevalence of acute and chronic diseases, such as diabetes, high blood pressure, and cancer, rising cases of neurological, oncological, infectious, and gastrointestinal disorders, and increasing number of clinical trials of new drugs and therapeutics are some of the principal factors driving the North America market revenue growth.
Check Our Prices@ https://www.emergenresearch.com/select-license/376
Major Companies in the Market Include:
- Bayer AG
- DuPont de Nemours, Inc.
- Sanofi S.A.
- Procter & Gamble Company
- Koninklijke DSM N.V.
- Probi AB
- Immuron Ltd.
- BioGaia AB
- Ingredion Incorporated
- Yakult Honsha Co., Ltd.
For the purpose of this report, Emergen Research has segmented the global human microbiome modulators market based on product type, application, and region:
Product Type Outlook (Revenue, USD Billion; 2017-2027)
- Prebiotics and Dietary Supplements
- Probiotics and Creams
Application Outlook (Revenue, USD Billion; 2017-2027)
- Neurological Disorders
- Dermatological Diseases
- Gastrointestinal Diseases
- Metabolic Disorders
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market
Region Outlook (Revenue, USD Billion; 2017–2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Take a Look at our Related Reports:
Blood Collection Market By Product (Needles, Tubes, Blood Bags, Monitors, Others), By Method (Automated, Manual), By Application (Therapeutic and Diagnostics), By End-Use (Hospital and Nursing Home, Diagnostic & Pathology Laboratories, Blood Banks, Others), and By Region Forecast to 2028
Durable Medical Equipment Market By Product Type (Bathroom Safety Devices and Medical Furniture, Personal Mobility Devices, Monitoring and Therapeutic Devices), By Payer (Private, Public, Out-of-Pocket), By End-Use (Clinics, Hospitals, Long Term Care Centers, Home Care Settings, Ambulatory Surgical Centers, and Others), and By Region Forecast to 2028
Oligonucleotide Synthesis Market By Product (Linkers, Synthesized Oligonucleotides, Equipment, Probe, Adaptor, Reagent), By Application (Therapeutic, Research, Diagnostics), By End-Use (Pharmaceutical, Hospitals, Biotechnology, Laboratories), By Region Forecasts to 2027
Tissue Imaging Market By Technology, By Products, By Application, By End-Users, Forecasts to 2027
Gut Microbiome Test Market Analysis By Product Type (Gut Microbiome Testing Kit, Others), By Application (Homecare Settings, Hospitals, Clinics & Laboratories, Others), By Region, Forecast to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release: https://www.emergenresearch.com/press-release/global-human-microbiome-modulators-market